Skandinaviska Enskilda Banken Ab (Publ) Ideaya Biosciences, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $20.3 Billion
- Q1 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 32,544 shares of IDYA stock, worth $1.14 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,544
Previous 19,611
65.95%
Holding current value
$1.14 Million
Previous $697,000
104.88%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IDYA
# of Institutions
206Shares Held
71.2MCall Options Held
29.8KPut Options Held
8.5K-
Black Rock Inc. New York, NY5.97MShares$209 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.86MShares$170 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.16MShares$146 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.05MShares$142 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$134 Million0.09% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.69B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...